About Tapasin-related protein
Tapasin-related protein (TAPBPL) is a protein
from Homo sapiens identified by UniProt accession
Q9BX59, 468 residues long.
MolForge cross-references it against 0 known binders and
37 disease associations.
Target properties
| Protein name | Tapasin-related protein |
| UniProt accession | Q9BX59 |
| Gene | TAPBPL |
| Organism | Homo sapiens |
| Length | 468 residues |
| Molecular weight | — |
| EC numbers | — |
| Target class | UNCLASSIFIED |
| Subcellular location | — |
| Keywords | — |
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
| Druggability score | — |
| Pocket score | — |
| Max clinical phase | — |
Disease associations (37)
Diseases linked to this target (Open Targets).
- blood protein measurement · score 0.21
- body height · score 0.14
- Back pain · score 0.09
- neoplasm · score 0.05
- cortical surface area measurement · score 0.05
- neurofibrillary tangles measurement · score 0.05
- mean platelet volume · score 0.04
- erythrocyte count · score 0.04
- brain measurement · score 0.04
- mean corpuscular volume · score 0.03
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
| AF-Q9BX59-F1 | alphafold | PREDICTED | 79.05 | — |
Amino-acid sequence (468 residues)
MGTQEGWCLL LCLALSGAAE TKPHPAEGQW RAVDVVLDCF LAKDGAHRGA LASSEDRARA SLVLKQVPVL DDGSLEDFTD FQGGTLAQDD PPIIFEASVD LVQIPQAEAL LHADCSGKEV TCEISRYFLQ MTETTVKTAA WFMANMQVSG GGPSISLVMK TPRVTKNEAL WHPTLNLPLS PQGTVRTAVE FQVMTQTQSL SFLLGSSASL DCGFSMAPGL DLISVEWRLQ HKGRGQLVYS WTAGQGQAVR KGATLEPAQL GMARDASLTL PGLTIQDEGT YICQITTSLY RAQQIIQLNI QASPKVRLSL ANEALLPTLI CDIAGYYPLD VVVTWTREEL GGSPAQVSGA SFSSLRQSVA GTYSISSSLT AEPGSAGATY TCQVTHISLE EPLGASTQVV PPERRTALGV IFASSLFLLA LMFLGLQRRQ APTGLGLLQA ERWETTSCAD TQSSHLHEDR TARVSQPS
Explore Tapasin-related protein with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets